tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Exact Sciences price target lowered to $55 from $65 at Barclays

Barclays lowered the firm’s price target on Exact Sciences (EXAS) to $55 from $65 and keeps an Overweight rating on the shares following the earnings report. The firm says not a lot changed in blood-based screening market dynamics over the long term.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1